Solazyme, Inc. (NASDAQ:SZYM) most recently reported quarterly actual earnings per share of $N/A for the period ending on N/A. Prior to the company reporting, consensus estimates based on data from Zacks Research projected the company to report EPS of $N/A. The difference between the estimate and the actual EPS was $N/A creating a surprise factor of N/A%. Currently, the company has an impact score of 39. The likelihood that the stock will move on news is greater with a higher impact score. According to Beta Research, the stock has a sentiment score of -0.145. On a scale between 1 and -1, a positive score tends to portray a favorable view of company results by news outlets. The opposite is true for a negative sentiment score.

In taking a look at where the stock might be headed, analysts have a consensus price target of $N/A on the shares. The most bullish brokerage firm has a $N/A target, while the most bearish sees the stock headed towards $N/A. This is according to the N/A estimates taken into consideration by Zacks Research.

In terms of Buy/Sell recommendations, analysts have a consensus rating of N/A. This is according to a simplified scale where 1 represents a Strong Buy and 5 a Strong Sell recommendation. There were N/A recommendations taking into account in order to arrive at this number. Of the N/A, N/A have a Strong Buy rating and N/A are rating it a Buy.

Solazyme, Inc. operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels. The Company also offers marine and microaquatic compounds for health and wellness products. Its products are used for biofuel production, replacements for fossil petroleum, and plant oils in various products ranging from green household cleaning supplies to cosmetics and foods. The Company serves renewable energy and industrial chemicals markets, as well as specialty ingredients markets in cosmetic, nutritional, and pharmaceutical products.

Solazyme, Inc. - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with’s FREE daily email newsletter.